These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29769410)

  • 21. Mechanisms of Primary Membranous Nephropathy.
    Gu Y; Xu H; Tang D
    Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33808418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical significance of the determination of antibodies to thrombospondin type 1 containing domain 7A (THSD7A) in membranous nephropathy].
    Kakhsurueva PA; Kamyshova ES; Bobkova IN; Stavrovskaya EV; Rudenko TE; Andreeva EY
    Ter Arkh; 2023 Aug; 95(6):462-467. PubMed ID: 38158964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and prognosis of malignancy in THSD7A-associated membranous nephropathy: a systematic literature review and clinical case study.
    Xu Q; Li J; Yang Y; Zhuo L; Gao H; Jiang S; Li W
    Ren Fail; 2024 Dec; 46(1):2355353. PubMed ID: 38785304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular classification of membranous nephropathy.
    Pozdzik A; Touzani F; Brochériou I; Corazza F
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):336-344. PubMed ID: 31045661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEGF-A Links Angiolymphoid Hyperplasia With Eosinophilia (ALHE) to THSD7A Membranous Nephropathy: A Report of 2 Cases.
    Matsumoto A; Matsui I; Namba T; Sakaguchi Y; Mizuno H; Shirayama Y; Shimada K; Hashimoto N; Doi Y; Yamaguchi S; Kubota K; Oka T; Mori D; Akiyama S; Hamano T; Mizui M; Takabatake Y; Kaneko T; Isaka Y
    Am J Kidney Dis; 2019 Jun; 73(6):880-885. PubMed ID: 30554801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy.
    Zhang C; Zhang M; Chen D; Ren Q; Xu W; Zeng C; Qin W; Liu Z
    J Clin Pathol; 2019 Oct; 72(10):705-711. PubMed ID: 31243053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombospondin Type 1 Domain-Containing 7A Localizes to the Slit Diaphragm and Stabilizes Membrane Dynamics of Fully Differentiated Podocytes.
    Herwig J; Skuza S; Sachs W; Sachs M; Failla AV; Rune G; Meyer TN; Fester L; Meyer-Schwesinger C
    J Am Soc Nephrol; 2019 May; 30(5):824-839. PubMed ID: 30971456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unmet challenges in membranous nephropathy.
    Salant DJ
    Curr Opin Nephrol Hypertens; 2019 Jan; 28(1):70-76. PubMed ID: 30451735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN.
    Ren S; Wu C; Zhang Y; Wang AY; Li G; Wang L; Hong D
    Ren Fail; 2018 Nov; 40(1):306-313. PubMed ID: 29623759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the N-terminal domain.
    Fresquet M; Rhoden SJ; Jowitt TA; McKenzie EA; Roberts I; Lennon R; Brenchley PE
    J Autoimmun; 2020 Jan; 106():102308. PubMed ID: 31395435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. THSD7A-associated membranous nephropathy in a patient with neurofibromatosis type 1.
    Lin F; Zhang D; Chang J; Tang X; Guan W; Jiang G; Zhu C; Bian F
    Eur J Med Genet; 2018 Feb; 61(2):84-88. PubMed ID: 29079545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membranous nephropathy-one morphologic pattern with different diseases.
    Hoxha E; von Haxthausen F; Wiech T; Stahl RAK
    Pflugers Arch; 2017 Aug; 469(7-8):989-996. PubMed ID: 28555350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy.
    Zhang P; Huang W; Zheng Q; Tang J; Dong Z; Jiang Y; Liu Y; Liu W
    J Immunol Res; 2021; 2021():8163298. PubMed ID: 34337081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case Report: THSD7A-Positive Membranous Nephropathy Caused by Tislelizumab in a Lung Cancer Patient.
    Chen M; Zhang L; Zhong W; Zheng K; Ye W; Wang M
    Front Immunol; 2021; 12():619147. PubMed ID: 34040602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is primary membranous nephropathy a complement mediated disease?
    Reinhard L; Stahl RAK; Hoxha E
    Mol Immunol; 2020 Dec; 128():195-204. PubMed ID: 33142137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity.
    Larsen CP; Cossey LN; Beck LH
    Mod Pathol; 2016 Apr; 29(4):421-6. PubMed ID: 26847174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.
    Pozdzik A; Brochériou I; David C; Touzani F; Goujon JM; Wissing KM
    Biomed Res Int; 2018; 2018():6281054. PubMed ID: 29511687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PLA2R and THSD7A: Disparate Paths to the Same Disease?
    Beck LH
    J Am Soc Nephrol; 2017 Sep; 28(9):2579-2589. PubMed ID: 28674044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Essential Roles for Mannose-Binding Lectin-Associated Serine Protease-1/3 in the Development of Lupus-Like Glomerulonephritis in MRL/
    Machida T; Sakamoto N; Ishida Y; Takahashi M; Fujita T; Sekine H
    Front Immunol; 2018; 9():1191. PubMed ID: 29892304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Membranous glomerulonephritis : An example of individualized medicine in nephrology].
    Stahl RAK; Hoxha E
    Internist (Berl); 2019 May; 60(5):440-449. PubMed ID: 30859275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.